Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Description

This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University with 40 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

Conditions

Autism Spectrum Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University with 40 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Condition
Autism Spectrum Disorder
Intervention / Treatment

-

Contacts and Locations

Syracuse

Golisano Center for Special Needs, Syracuse, New York, United States, 13210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ages 2 - 8
  • * Autism spectrum disorder diagnosis
  • * CARS-2 score of 30 - 45
  • * CARS scores less than 30 or over 45.
  • * Taking psychotropic medications.
  • * Having skin lesions on scalp
  • * Having history of seizures
  • * Having history of abnormal EEG
  • * Being a relative of the PI or a researcher
  • * Having implanted devices (including cochlear implants).

Ages Eligible for Study

2 Years to 8 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

State University of New York - Upstate Medical University,

Study Record Dates

2024-08-15